Charles Schoch
Fortune : 360 145 $ au 31/05/2026
Fortune : 360 145 $ au 31/05/2026
Charles Schoch is Chief Financial Officer, Secretary & Treasurer at Candel Therapeutics, Inc. since 2024.
Previously, Mr. Schoch was Controller at Corbus Pharmaceuticals, Inc. from 2020 to 2021.
Education includes undergraduate studies at Elon University and graduate studies including an MBA at Northeastern University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 43 391 ( 0,06 % ) | 360 145 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur Financier/CFO | 12/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 01/11/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Elon University
Elon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national